← Leaderboards
R. Paul Johnson
Harvard University (Medical School)
$56,310,063
Attributed
$56,692,011
Total exposure
56
Grants
42
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $22.6M · FY2005–25$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$110,880,938 · 58
By mechanism
U19$40,989,044 · 3
P01$29,887,374 · 10
C06$14,868,223 · 1
R01$8,991,269 · 4
P30$7,866,614 · 3
P51$6,237,370 · 33
Top collaborators
- Dan H. Barouch5 shared
- John H Morrison3 shared
- Jay Rappaport3 shared
- Robert B Norgren2 shared
Most similar at Harvard University (Medical School)
Same institution · by research overlap
- Richard T Born$14,598,941
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelImmune ResponseFundingMacaca MulattaGrantInfectionResourcesUnited States National Institutes Of HealthMacacaNonhuman PrimateImmunologyAnimalsAcquired Immunodeficiency SyndromeBaseAids VaccinesSourceViralResponseSimian Immunodeficiency VirusT-LymphocyteFlow CytometryProgramsVaginaGene Therapy
Grant awards (135)
Core H: Systems Immunology$321,420
P30 · FY2025 · AI · contact PI
Core H: Systems Immunology$228,635
P30 · FY2024 · AI · contact PI
Annual Symposium on Nonhuman Primates$74,999
R13 · FY2024 · OD · contact PI
Core H: Systems Immunology$240,673
P30 · FY2023 · AI · contact PI
Annual Symposium on Nonhuman Primates$74,999
R13 · FY2023 · OD · contact PI
Core H: Systems Immunology$542,470
P30 · FY2022 · AI · contact PI
Annual Symposium on Nonhuman Primates$74,999
R13 · FY2022 · OD · contact PI
Core H: Immunology Core$234,359
P30 · FY2021 · AI · contact PI
Core H: Immunology Core$428,321
P30 · FY2020 · AI · contact PI
Core H: Immunology Core$447,967
P30 · FY2019 · AI · contact PI
Core H: Immunology Core$365,337
P30 · FY2018 · AI · contact PI
Core H: Immunology Core$371,133
P30 · FY2017 · AI · contact PI
Exome screening and directed breeding of rhesus for human genetic disease models$247,872
R21 · FY2016 · OD
Consortium for AIDS Vaccine Research in Nonhuman Primates$7,440,564
U19 · FY2015 · AI
Live Attenuated SIV-Mediated Protection Against Mucosal SIV Infection$566,342
U19 · FY2015 · AI · contact PI
Immunology$429,528
U19 · FY2015 · AI · contact PI
Exome screening and directed breeding of rhesus for human genetic disease models$216,028
R21 · FY2015 · OD
Consortium for AIDS Vaccine Research in Nonhuman Primates$7,888,838
U19 · FY2014 · AI
Live Attenuated SIV-Mediated Protection Against Mucosal SIV Infection$457,751
U19 · FY2014 · AI · contact PI
Immunology$445,195
U19 · FY2014 · AI · contact PI
Consortium for AIDS Vaccine Research in Nonhuman Primates$6,572,396
U19 · FY2013 · AI
The NEPRC SPF Rhesus Macaque Breeding Colony$761,303
U42 · FY2013 · OD · contact PI
Natural killer cells and control of SIV infection$710,669
R01 · FY2013 · AI · contact PI
Developmental$703,521
P30 · FY2013 · AI · contact PI
Live Attenuated SIV-Mediated Protection Against Mucosal SIV Infection$572,602
U19 · FY2013 · AI · contact PI
Immunology$487,804
U19 · FY2013 · AI · contact PI
Consortium for AIDS Vaccine Research in Nonhuman Primates$6,991,909
U19 · FY2012 · AI
Developmental$1,494,199
P30 · FY2012 · AI · contact PI
Natural killer cells and control of SIV infection$756,033
R01 · FY2012 · AI · contact PI
Live Attenuated SIV-Mediated Protection Against Mucosal SIV Infection$714,064
U19 · FY2012 · AI · contact PI
Immunology$442,151
U19 · FY2012 · AI · contact PI
Consortium for AIDS Vaccine Research in Nonhuman Primates$7,013,564
U19 · FY2011 · AI
Mechanisms of protective immunity induced by live attenuated SIV vaccines$3,233,225
P01 · FY2011 · AI · contact PI
Developmental$990,284
P30 · FY2011 · AI · contact PI
Mechanisms of mucosal protection induced by attenuated SIV$801,307
P01 · FY2011 · AI · contact PI
Natural killer cells and control of SIV infection$733,601
R01 · FY2011 · AI · contact PI
Live Attenuated SIV-Mediated Protection Against Mucosal SIV Infection$601,619
U19 · FY2011 · AI · contact PI
Immunology and Virology Core$487,617
P01 · FY2011 · AI · contact PI
Immunology$364,717
U19 · FY2011 · AI · contact PI
Administration Core$261,965
P01 · FY2011 · AI · contact PI
SURVIVAL OF THE FITTEST: CHALLENGING TRANSDUCED CELLS WITH HIV-1 REPLICATION$195,436
P51 · FY2011 · RR · contact PI
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION$195,436
P51 · FY2011 · RR · contact PI
MODULATION OF PD-1 EXPRESSION ON T CELLS IN SIV-INFECTED MACAQUES$195,436
P51 · FY2011 · RR · contact PI
DELINEATION OF MULTIPLE SUBPOPULATIONS OF NATURAL KILLER CELLS IN MONKEYS$193,907
P51 · FY2011 · RR · contact PI
Construction of a Dual Function Primate Facility: ABSL3 and Transplant Medicine$14,868,223
C06 · FY2010 · RR · contact PI
Mechanisms of protective immunity induced by live attenuated SIV vaccines$3,370,567
P01 · FY2010 · AI · contact PI
Mechanisms of mucosal protection induced by attenuated SIV$823,181
P01 · FY2010 · AI · contact PI
Natural killer cells and control of SIV infection$794,742
R01 · FY2010 · AI · contact PI
Developmental$745,625
P30 · FY2010 · AI · contact PI
Immunology and Virology Core$501,697
P01 · FY2010 · AI · contact PI
Administration Core$271,456
P01 · FY2010 · AI · contact PI
SURVIVAL OF THE FITTEST: CHALLENGING TRANSDUCED CELLS WITH HIV-1 REPLICATION$202,435
P51 · FY2010 · RR · contact PI
MODULATION OF PD-1 EXPRESSION ON T CELLS IN SIV-INFECTED MACAQUES$202,435
P51 · FY2010 · RR · contact PI
CD8+ T CELLS AND PROTECTION AGAINST VAGINAL CHALLENGE INDUCED BY SIVMAC239DELTA3$202,435
P51 · FY2010 · RR · contact PI
DELINEATION OF MULTIPLE SUBPOPULATIONS OF NATURAL KILLER CELLS IN MONKEYS$202,435
P51 · FY2010 · RR · contact PI
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION$202,435
P51 · FY2010 · RR · contact PI
Mechanisms of protective immunity induced by live attenuated SIV vaccines$197,490
P01 · FY2010 · AI · contact PI
Mechanisms of protective immunity induced by live attenuated SIV vaccines$3,990,219
P01 · FY2009 · AI · contact PI
Mechanisms of mucosal protection induced by attenuated SIV$933,169
P01 · FY2009 · AI · contact PI
Developmental$752,670
P30 · FY2009 · AI · contact PI
Immunology and Virology Core$537,336
P01 · FY2009 · AI · contact PI
Administration Core$307,041
P01 · FY2009 · AI · contact PI
MODULATION OF PD-1 EXPRESSION ON T CELLS IN SIV-INFECTED MACAQUES$199,721
P51 · FY2009 · RR · contact PI
CD8+ T CELLS AND PROTECTION AGAINST VAGINAL CHALLENGE INDUCED BY SIVMAC239DELTA3$199,721
P51 · FY2009 · RR · contact PI
DELINEATION OF MULTIPLE SUBPOPULATIONS OF NATURAL KILLER CELLS IN MONKEYS$199,721
P51 · FY2009 · RR · contact PI
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION$199,721
P51 · FY2009 · RR · contact PI
SURVIVAL OF THE FITTEST: CHALLENGING TRANSDUCED CELLS WITH HIV-1 REPLICATION$199,721
P51 · FY2009 · RR · contact PI
Protective immunity induced by live attenuated SIV$171,331
R01 · FY2009 · AI · contact PI
Mechanisms of protective immunity induced by live attenuated SIV vaccines$3,801,627
P01 · FY2008 · AI · contact PI
Mechanisms of mucosal protection induced by attenuated SIV$870,309
P01 · FY2008 · AI · contact PI
Protective immunity induced by live attenuated SIV$574,877
R01 · FY2008 · AI · contact PI
Immunology and Virology Core$506,836
P01 · FY2008 · AI · contact PI
Administration Core$288,050
P01 · FY2008 · AI · contact PI
INHIBITION OF SHIV REPLICATION BY HIV-SPECIFIC APTAMERS$129,768
P51 · FY2008 · RR · contact PI
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION$129,768
P51 · FY2008 · RR · contact PI
MODULATION OF PD-1 EXPRESSION ON T CELLS IN SIV-INFECTED MACAQUES$129,768
P51 · FY2008 · RR · contact PI
DELINEATION OF MULTIPLE SUBPOPULATIONS OF NATURAL KILLER CELLS IN MONKEYS$129,768
P51 · FY2008 · RR · contact PI
CD8+ T CELLS AND PROTECTION AGAINST VAGINAL CHALLENGE INDUCED BY SIVMAC239DELTA3$129,768
P51 · FY2008 · RR · contact PI
Mechanisms of protective immunity induced by live attenuated SIV vaccines$3,688,528
P01 · FY2007 · AI · contact PI
Mechanisms of mucosal protection induced by attenuated SIV$850,843
P01 · FY2007 · AI · contact PI
Protective immunity induced by live attenuated SIV$568,944
R01 · FY2007 · AI · contact PI
Immunology and Virology Core$503,291
P01 · FY2007 · AI · contact PI
Administrative Core$328,501
P01 · FY2007 · AI · contact PI
Analysis of aptamer efficacy in SHIV-infected macaques$304,975
P01 · FY2007 · AI · contact PI
DELINEATION OF MULTIPLE SUBPOPULATIONS OF NATURAL KILLER CELLS IN MONKEYS$52,049
P51 · FY2007 · RR · contact PI
INHIBITION OF SHIV REPLICATION BY HIV-SPECIFIC APTAMERS$52,049
P51 · FY2007 · RR · contact PI
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION$52,049
P51 · FY2007 · RR · contact PI
Protective immunity induced by live attenuated SIV$626,106
R01 · FY2006 · AI · contact PI
Stem Cell Gene Therapy for AIDS$332,425
R01 · FY2006 · CA · contact PI
Analysis of aptamer efficacy in SHIV-infected macaques$314,060
P01 · FY2006 · AI · contact PI
INHIBITION OF SHIV REPLICATION BY HIV-SPECIFIC APTAMERS$134,807
P51 · FY2006 · RR · contact PI
CELLULAR IMMUNE RESPONSES INDUCED BY ATTENUATED SIV CONTRIBUTE TO PROTECTION$134,807
P51 · FY2006 · RR · contact PI
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION$134,807
P51 · FY2006 · RR · contact PI
DELINEATION OF MULTIPLE SUBPOPULATIONS OF NATURAL KILLER CELLS IN RHESUS MACAQUE$134,807
P51 · FY2006 · RR · contact PI
GENE THERAPY FOR BRAIN TUMORS$48,941
P51 · FY2006 · RR · contact PI
Protective immunity induced by live attenuated SIV$537,109
R01 · FY2005 · AI
Stem Cell Gene Therapy for AIDS$340,425
R01 · FY2005 · CA
Analysis of aptamer efficacy in SHIV-infected macaques$306,174
P01 · FY2005 · AI
CELLULAR IMMUNE RESPONSES INDUCED BY ATTENUATED SIV CONTRIBUTE TO PROTECTION$168,102
P51 · FY2005 · RR
INHIBITION OF SHIV REPLICATION BY HIV-SPECIFIC APTAMERS$168,102
P51 · FY2005 · RR
DELINEATION OF MULTIPLE SUBPOPULATIONS OF NATURAL KILLER CELLS IN MONKEYS$168,102
P51 · FY2005 · RR
GENE THERAPY FOR BRAIN TUMORS$81,519
P51 · FY2005 · RR
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION$69,059
P51 · FY2005 · RR
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION$630,656
P51 · FY2004 · RR
Protective immunity induced by live attenuated SIV$521,465
R01 · FY2004 · AI
Stem Cell Gene Therapy for AIDS$409,125
R01 · FY2004 · CA
Induction of mucosal immunity by DNA/MVA vaccines$296,625
R21 · FY2004 · AI
Analysis of aptamer efficacy in SHIV-infected macaques$279,153
P01 · FY2004 · AI
INHIBITION OF SHIV REPLICATION BY HIV-SPECIFIC APTAMERS$204,218
P51 · FY2004 · RR
CELLULAR IMMUNE RESPONSES INDUCED BY ATTENUATED SIV$204,218
P51 · FY2004 · RR
GENE THERAPY FOR BRAIN TUMORS$112,320
P51 · FY2004 · RR
Stem Cell Gene Therapy for AIDS$340,425
R01 · FY2003 · CA
Induction of mucosal immunity by DNA/MVA vaccines$294,219
R21 · FY2003 · AI
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION$246,923
P51 · FY2003 · RR
CD4+ T CELL FUNCTION IN SIV-INFECTED MACAQUES$350,125
R01 · FY2002 · AI
Stem Cell Gene Therapy for AIDS$306,383
R01 · FY2002 · CA
XENOGENEIC IMMUNE RECONSTITUTION IN SIV INFECTION$256,338
P01 · FY2002 · AI
HIV/FIV vectors for stem cell gene therapy$247,465
P01 · FY2002 · AI
CELLULAR IMMUNE RESPONSES TO LIVE ATTENUATED SIV VACCINES$0
P01 · FY2002 · AI
INTERACTIONS BETWEEN IMMUNE SYSTEM AND VIRAL ONCOLYSIS$0
P01 · FY2002 · CA
SV40 vectors for stem cell gene therapy in Macaques$0
P01 · FY2002 · AI
CD4+ T CELL FUNCTION IN SIV-INFECTED MACAQUES$299,288
R01 · FY2001 · AI
XENOGENEIC IMMUNE RECONSTITUTION IN SIV INFECTION$256,338
P01 · FY2001 · AI
HIV/FIV vectors for stem cell gene therapy$247,465
P01 · FY2001 · AI
INTERACTIONS BETWEEN IMMUNE SYSTEM AND VIRAL ONCOLYSIS$0
P01 · FY2001 · CA
SV40 vectors for stem cell gene therapy in Macaques$0
P01 · FY2001 · AI
CELLULAR IMMUNE RESPONSES TO LIVE ATTENUATED SIV VACCINES$0
P01 · FY2001 · AI
CELLULAR IMMUNE RESPONSES TO LIVE ATTENUATED SIV VACCINES$448,605
P01 · FY2000 · AI
STEM CELL GENE THERAPY FOR AIDS$327,621
R01 · FY2000 · CA
CD4+ T CELL FUNCTION IN SIV-INFECTED MACAQUES$290,575
R01 · FY2000 · AI
XENOGENEIC IMMUNE RECONSTITUTION IN SIV INFECTION$256,338
P01 · FY2000 · AI
HIV/FIV vectors for stem cell gene therapy$208,104
P01 · FY2000 · AI
HIV/FIV vectors for stem cell gene therapy$208,104
P01 · FY2000 · AI
SV40 vectors for stem cell gene therapy in Macaques$0
P01 · FY2000 · AI
INTERACTIONS BETWEEN IMMUNE SYSTEM AND VIRAL ONCOLYSIS$0
P01 · FY2000 · CA